Rekvina Laboratories accepts resignation of MD Amit Mukesh Shah
- Rekvina Laboratories accepts resignation of Amit Mukesh Shah as MD and Director
- Effective date of resignation is September 11, 2026
- Cited reason is personal commitments and personal reasons
- Filing made to BSE under Regulation 30 of SEBI Listing Regulations

*this image is generated using AI for illustrative purposes only.
Rekvina Laboratories has accepted the resignation of Amit Mukesh Shah from the positions of Managing Director and Director, effective September 11, 2026.
The company disclosed the development in a filing with the Bombay Stock Exchange on September 12, 2026. The intimation was issued pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Resignation Details
Mr. Shah tendered his resignation due to personal reasons and personal commitments. In his letter to the Chairman, dated September 11, 2026, he confirmed that his departure is solely attributable to these factors and stated there are no other reasons for his resignation.
The Board of Directors formally accepted the resignation through a communication signed by Surbhit Mukesh Shah, Director, on September 12, 2026. The filing included details required under SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023.
No financial data or operational metrics were disclosed in this regulatory filing.
Historical Stock Returns for Rekvina Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.99% | +12.54% | +93.61% | +102.66% | 0.0% | 0.0% |
Who has been appointed or nominated as the interim Managing Director to ensure operational continuity during the transition?
Will Rekvina Laboratories initiate a search for a permanent replacement for Amit Mukesh Shah, and what is the expected timeline for this process?
How might this leadership change impact the company's ongoing strategic initiatives or R&D pipeline at Rekvina Laboratories?


































